{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:17:28Z","timestamp":1781810248130,"version":"3.54.5"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The incidence of certain vaccine-preventative diseases, such as influenza, herpes zoster and pneumococcal infection, continues to be high despite the availability of vaccines, resulting in a substantial health and economic burden on society, particularly among older adults aged \u226565\u2009years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cost calculator was developed to assess the cost of illness of influenza, herpes zoster and pneumococcal disease in France. Direct medical costs related to diagnosis and treatment in the older adult population in both inpatient and outpatient settings were modelled over a 1-year time horizon. Scenario analyses were conducted to determine the impact of hospitalizations on the results by considering only influenza-attributed diagnoses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In France, influenza has the highest incidence, followed by herpes zoster and pneumococcal disease. Similarly, influenza poses the greatest cost burden among all older adults, while pneumococcal disease poses the greatest cost burden among those aged 65\u201374\u2009years. When considering only influenza-attributed diagnoses, the number of inpatient visits and associated costs was reduced by 63% in the overall older adult population. In the low-incidence season, the number of inpatient visits and associated costs were reduced by 69%, while in the high-incidence season, the number of inpatient visits and associated costs increased by 63%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Influenza remains a leading vaccine-preventable disease among older adults in France, resulting in a substantial economic burden that could be prevented by increasing vaccine uptake.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurpub\/ckad212","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T22:47:39Z","timestamp":1701989259000},"page":"170-175","source":"Crossref","is-referenced-by-count":4,"title":["Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France"],"prefix":"10.1093","volume":"34","author":[{"given":"Lauren","family":"Brown","sequence":"first","affiliation":[{"name":"Evidera , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J","family":"Sutton","sequence":"additional","affiliation":[{"name":"Evidera , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle","family":"Browne","sequence":"additional","affiliation":[{"name":"Evidera , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Bartelt-Hofer","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines , Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Greiner","sequence":"additional","affiliation":[{"name":"University of Bielefeld , Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Petitjean","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines , Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Roiz","sequence":"additional","affiliation":[{"name":"Evidera , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2024020601165655600_ckad212-B1","author":"European Centre for Disease Prevention and Control","year":"2021"},{"key":"2024020601165655600_ckad212-B2","author":"World Health Organization","year":"2021"},{"key":"2024020601165655600_ckad212-B3","author":"World Health Organization","year":"2021"},{"key":"2024020601165655600_ckad212-B4","author":"World Health Organization"},{"key":"2024020601165655600_ckad212-B5","author":"World Health Organization","year":"2018"},{"key":"2024020601165655600_ckad212-B6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/21645515.2015.1086047","article-title":"Influenza: can we cope better with the unpredictable?","volume":"12","author":"Dos Santos","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2024020601165655600_ckad212-B7","author":"World Health Organization"},{"key":"2024020601165655600_ckad212-B8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.vaccine.2021.11.080","article-title":"Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project","volume":"40","author":"Paget","year":"2022","journal-title":"Vaccine"},{"key":"2024020601165655600_ckad212-B9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/irv.12962","article-title":"Estimating the burden of influenza-related and associated hospitalizations and deaths in France: an eight-season data study, 2010\u20132018","volume":"16","author":"Lemaitre","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"key":"2024020601165655600_ckad212-B10","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"2024020601165655600_ckad212-B11","author":"European Centre for Disease Prevention and Control","year":"2021"},{"key":"2024020601165655600_ckad212-B12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10935-015-0394-3","article-title":"Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013","volume":"36","author":"McLaughlin","year":"2015","journal-title":"J Prim Prev"},{"key":"2024020601165655600_ckad212-B13","author":"European centre for Disease Prevention and Control","year":"2021"},{"key":"2024020601165655600_ckad212-B14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-019-03485-3","article-title":"Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe","volume":"38","author":"Bonnave","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024020601165655600_ckad212-B15","author":"Organisation for Economic Co-operation and Development","year":"2023"},{"key":"2024020601165655600_ckad212-B16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/geriatrics7010004","article-title":"The health professional\u2019s view on the inclusion of age in the recommendations for pneumococcal vaccination: results of a cross-sectional survey in France","volume":"7","author":"Farge","year":"2021","journal-title":"Geriatrics"},{"key":"2024020601165655600_ckad212-B17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12879-015-1059-9","article-title":"Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France","volume":"15","author":"Blein","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2024020601165655600_ckad212-B18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/bmj.320.7245.1335","article-title":"Economic note: cost of illness studies","volume":"320","author":"Byford","year":"2000","journal-title":"BMJ"},{"key":"2024020601165655600_ckad212-B19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/2046-4053-3-47","article-title":"Micro-costing studies in the health and medical literature: protocol for a systematic review","volume":"3","author":"Xu","year":"2014","journal-title":"Syst Rev"},{"key":"2024020601165655600_ckad212-B20","year":"2019"},{"key":"2024020601165655600_ckad212-B21","author":"Fouad","year":"2020"},{"key":"2024020601165655600_ckad212-B22"},{"key":"2024020601165655600_ckad212-B23","first-page":"1","year":"2016"},{"key":"2024020601165655600_ckad212-B24","year":"2018"},{"key":"2024020601165655600_ckad212-B25","author":"Sant\u00e9 Publique France"},{"key":"2024020601165655600_ckad212-B26","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS One"},{"key":"2024020601165655600_ckad212-B27","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.vaccine.2016.03.013","article-title":"CAPECO: cost evaluation of community acquired pneumonia managed in primary care","volume":"34","author":"Personne","year":"2016","journal-title":"Vaccine"},{"key":"2024020601165655600_ckad212-B28","author":"Sentinelles","year":"2021"},{"key":"2024020601165655600_ckad212-B29","doi-asserted-by":"crossref","first-page":"e009689","DOI":"10.1136\/bmjopen-2015-009689","article-title":"Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study","volume":"6","author":"Pickering","year":"2016","journal-title":"BMJ Open"},{"key":"2024020601165655600_ckad212-B30","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1080\/21645515.2016.1180490","article-title":"Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe","volume":"12","author":"Uhart","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2024020601165655600_ckad212-B31","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1080\/21645515.2015.1011957","article-title":"A comparative public health and budget impact analysis of pneumococcal vaccines: the French case","volume":"11","author":"Jiang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2024020601165655600_ckad212-B32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10198-017-0900-z","article-title":"Costs associated with community acquired pneumonia in France","volume":"19","author":"Saba","year":"2018","journal-title":"Eur J Health Econ"},{"key":"2024020601165655600_ckad212-B33","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1080\/21645515.2016.1184801","article-title":"Cost-effectiveness of a herpes zoster vaccination program among the French elderly people","volume":"12","author":"Belchior","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"2024020601165655600_ckad212-B34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/21645515.2020.1780847","article-title":"Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States","volume":"17","author":"Talbird","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2024020601165655600_ckad212-B35","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1016\/j.vaccine.2013.09.013","article-title":"Influenza cost and cost-effectiveness studies globally\u2014a review","volume":"31","author":"Peasah","year":"2013","journal-title":"Vaccine"},{"key":"2024020601165655600_ckad212-B36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.respe.2010.06.166","article-title":"Burden of herpes zoster and postherpetic neuralgia: incidence, proportion, and associated costs in the French population aged 50 or over","volume":"58","author":"Mick","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2024020601165655600_ckad212-B37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1186\/s12889-019-7458-x","article-title":"Epidemiology and cost of seasonal influenza in Germany\u2014a claims data analysis","volume":"19","author":"Scholz","year":"2019","journal-title":"BMC Public Health"},{"key":"2024020601165655600_ckad212-B38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"2024020601165655600_ckad212-B39","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1111\/ajt.16381","article-title":"Decreased influenza activity during the COVID-19 pandemic\u2014United States, Australia, Chile, and South Africa, 2020","volume":"20","author":"Olsen","year":"2020","journal-title":"Am J Transplant"}],"container-title":["European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurpub\/advance-article-pdf\/doi\/10.1093\/eurpub\/ckad212\/54093192\/ckad212.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/34\/1\/170\/56588109\/ckad212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/34\/1\/170\/56588109\/ckad212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T01:19:07Z","timestamp":1707182347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article\/34\/1\/170\/7462254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2024,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckad212","relation":{},"ISSN":["1101-1262","1464-360X"],"issn-type":[{"value":"1101-1262","type":"print"},{"value":"1464-360X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2023,12,7]]}}}